The latest Q3 has been reported since 2018 is Nov. 27That would be Monday.
The later is goes the more that can be updated. Will the 5X scale-up plant be completed on time and before the end of the year. Maybe its already essentially done.
The avenanthramide clinical trial should begin imminently based on Gilles October presentation.
The oat beta glucan powder was also expected to be launched very, very soon.
Some news could help cushion the blow of bad financials although the market might not care.